US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals

Watchlist
  • 17.880
  • +0.270+1.53%
Close Apr 26 16:00 ET
  • 17.880
  • 0.0000.00%
Post 16:13 ET
1.27BMarket Cap137.54P/E (TTM)

Kiniksa Pharmaceuticals Key Stats

Kiniksa Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Apr 23, 2024

Revenue(YoY)

79.86M

+65.18%
EPS(YoY)

-0.25

-38.89%

Strong Buy

Apr 24, 2024

Kiniksa Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 101.250M--
--2024/Q2-- / 91.777M--
Apr 23, 20242024/Q179.858M / 78.464M--
Feb 28, 20242023/Q483.395M / 72.272M--
Oct 31, 20232023/Q367.046M / 64.448M--
Jul 25, 20232023/Q271.473M / 52.196M--
May 2, 20232023/Q148.345M / 45.661M--
Feb 28, 20232022/Q461.884M / 45.116M--
Nov 1, 20222022/Q399.135M / 98.215M--
Aug 3, 20222022/Q226.972M / 28.552M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 101.250M--
--2024/Q2-- / 91.777M--
Apr 23, 20242024/Q179.858M / 78.464M--
Feb 28, 20242023/Q483.395M / 72.272M--
Oct 31, 20232023/Q367.046M / 64.448M--
Jul 25, 20232023/Q271.473M / 52.196M--
May 2, 20232023/Q148.345M / 45.661M--
Feb 28, 20232022/Q461.884M / 45.116M--
Nov 1, 20222022/Q399.135M / 98.215M--
Aug 3, 20222022/Q226.972M / 28.552M--

Unlock Free Earnings Estimates

Kiniksa Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 24, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg